Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function

Current Opinion in Structural Biology

Volumn 18, Issue 6, 2008, Pages 741-747

  Wang, Ling ^a   Tang, Yong ^b   Cole, Philip A ^a   Marmorstein, Ronen ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; RTT109 HISTONE ACETYLTRANSFERASE; UNCLASSIFIED DRUG;

ACETYLATION; BINDING AFFINITY; BIOCHEMISTRY; BIOLOGY; CATALYSIS; EVOLUTION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ACETYLATION; ANIMALS; BINDING SITES; CRYSTALLOGRAPHY; EVOLUTION, MOLECULAR; HISTONE ACETYLTRANSFERASES; HUMANS; P300-CBP TRANSCRIPTION FACTORS; SACCHAROMYCES CEREVISIAE PROTEINS;

METAZOA;

EID: 57049120143     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2008.09.004     Document Type: Review

References (52)

1. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., and Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84 (1996) 843-851
2. Kawasaki H., Schiltz L., Chiu R., Itakura K., Taira K., Nakatani Y., and Yokoyama K.K. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405 (2000) 195-200
3. Mizzen C.A., Yang X.-J., Kokubo T., Brownell J.E., Bannister A.J., Owen-Hughes T., Workman J., Wang L., Berger S.L., Kouzarides T., et al. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87 (1996) 1261-1270
4. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J.X., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389 (1997) 194-198
5. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., and Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90 (1997) 569-580
6. Doi M., Hirayama J., and Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell 125 (2006) 497-508
7. Yee S.P., and Branton P.E. Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology 147 (1985) 142-153
8. Harlow E., Whyte P., Franza Jr. B.R., and Schley C. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol 6 (1986) 1579-1589
9. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., and Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365 (1993) 855-859
10. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
11. Bannister A.J., and Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 384 (1996) 641-643
12. Petrij F., Giles R.H., Dauwerse H.G., Saris J.J., Hennekam R.C., Masuno M., Tommerup N., van Ommen G.J., Goodman R.H., Peters D.J., et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376 (1995) 348-351
13. Petrij F., Dorsman J.C., Dauwerse H.G., Giles R.H., Peeters T., Hennekam R.C., Breuning M.H., and Peters D.J. Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3). Am J Med Genet 92 (2000) 47-52
14. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J.M., Iwama T., and Miyaki M. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12 (1996) 1565-1569
15. Kishimoto M., Kohno T., Okudela K., Otsuka A., Sasaki H., Tanabe C., Sakiyama T., Hirama C., Kitabayashi I., Minna J.D., et al. Mutations and deletions of the CBP gene in human lung cancer. Clin Cancer Res 11 (2005) 512-519
16. Bryan E.J., Jokubaitis V.J., Chamberlain N.L., Baxter S.W., Dawson E., Choong D.Y., and Campbell I.G. Mutation analysis of EP300 in colon, breast and ovarian carcinomas. Int J Cancer 102 (2002) 137-141
17. Iyer N.G., Ozdag H., and Caldas C. p300/CBP and cancer. Oncogene 23 (2004) 4225-4231
18. Karamouzis M.V., Konstantinopoulos P.A., and Papavassiliou A.G. Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res 17 (2007) 324-332
19. Cong S.Y., Pepers B.A., Evert B.O., Rubinsztein D.C., Roos R.A., van Ommen G.J., and Dorsman J.C. Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci 30 (2005) 12-23
20. Lieberman A.P., Harmison G., Strand A.D., Olson J.M., and Fischbeck K.H. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet 11 (2002) 1967-1976
21. Francis Y.I., Diss J.K., Kariti M., Stephanou A., and Latchman D.S. p300 activation by Presenilin 1 but not by its M146L mutant. Neurosci Lett 413 (2007) 137-140
22. Yanazume T., Morimoto T., Wada H., Kawamura T., and Hasegawa K. Biological role of p300 in cardiac myocytes. Mol Cell Biochem 248 (2003) 115-119
23. Ghosh A.K., and Varga J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol 213 (2007) 663-671
24. Bennett C.B., Lewis L.K., Karthikeyan G., Lobachev K.S., Jin Y.H., Sterling J.F., Snipe J.R., and Resnick M.A. Genes required for ionizing radiation resistance in yeast. Nat Genet 29 (2001) 426-434
25. Chang M., Bellaoui M., Boone C., and Brown G.W. A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc Natl Acad Sci U S A 99 (2002) 16934-16939
26. Schneider J., Bajwa P., Johnson F.C., Bhaumik S.R., and Shilatifard A. Rtt109 is required for proper H3K56 acetylation: a chromatin mark associated with the elongating RNA polymerase II. J Biol Chem 281 (2006) 37270-37274. This manuscript was the first to correlate Rtt109 protein with the acetylation of lysine 56 of histone H3, although no direct HAT activity was demonstrated for Rtt109.
27. Driscoll R., Hudson A., and Jackson S.P. Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56. Science 315 (2007) 649-652. This manuscript showed that lysine 56 of histone H3 is acetylated by Rtt109 upon Asf1 stimulation to promote genome stability and DNA repair.
28. Han J., Zhou H., Horazdovsky B., Zhang K., Xu R.M., and Zhang Z. Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication. Science 315 (2007) 653-655. This manuscript showed that lysine 56 of histone H3 is acetylated by Rtt109, an essential event for genome stability and DNA repair.
29. Tsubota T., Berndsen C.E., Erkmann J.A., Smith C.L., Yang L., Freitas M.A., Denu J.M., and Kaufman P.D. Histone H3-K56 acetylation is catalyzed by histone chaperone-dependent complexes. Mol Cell 25 (2007) 703-712. This manuscript highlighted the essential roles of histone chaperones, Asf1 and Vps75, in the acetylation of lysine 56 of histone H3 by Rtt109.
30. Fillingham J., Recht J., Silva A.C., Suter B., Emili A., Stagljar I., Krogan N.J., Allis C.D., Keogh M.C., and Greenblatt J.F. Chaperone control of the activity and specificity of the histone H3 acetyltransferase Rtt109. Mol Cell Biol 28 (2008) 4342-4353. This manuscript was the first to show that Rtt109 has substrates other than lysine 56 of histone H3, showing that lysine 9 of histone H3 is also a target.
31. Han J., Zhou H., Li Z., Xu R.M., and Zhang Z. The Rtt109-Vps75 histone acetyltransferase complex acetylates non-nucleosomal histone H3. J Biol Chem 282 (2007) 14158-14164
32. Han J., Zhou H., Li Z., Xu R.M., and Zhang Z. Acetylation of lysine 56 of histone H3 catalyzed by RTT109 and regulated by ASF1 is required for replisome integrity. J Biol Chem 282 (2007) 28587-28596
33. Liu X., Wang L., Zhao K., Thompson P.R., Hwang Y., Marmorstein R., and Cole P.A. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451 (2008) 846-850. This manuscript reported the structure of the HAT domain of p300 bound to the Lys-CoA bisubstrate inhibitor as well as in vitro biochemical and enzymatic studies of wild-type and mutant p300 proteins to provide insights into catalysis and histone substrate binding by p300.
34. Trievel R.C., Rojas J.R., Sterner D.E., Venkataramani R.N., Wang L., Zhou J., Allis C.D., Berger S.L., and Marmorstein R. Crystal structure and mechanism of histone acetylation of the yeast GCN5 transcriptional coactivator. Proc Natl Acad Sci U S A 96 (1999) 8931-8936
35. Yan Y., Harper S., Speicher D.W., and Marmorstein R. The catalytic mechanism of the ESA1 histone acetyltransferase involves a self-acetylated intermediate. Nat Struct Biol 9 (2002) 862-869
36. Neuwald A.F., and Landsman D. GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein. Trends Biochem Sci 22 (1997) 154-155
37. Thompson P.R., Kurooka H., Nakatani Y., and Cole P.A. Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity. J Biol Chem 276 (2001) 33721-33729
38. Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D., An W., Ge Q., Roeder R.G., Wong J., et al. Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol 11 (2004) 308-315. This manuscript presented biochemical studies to demonstrate that p300 is autoacetylated, predominantly on an 'activation loop' to regulate its function.
39. Rojas J.R., Trievel R.C., Zhou J., Mo Y., Li X., Berger S.L., Allis C.D., and Marmorstein R. Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide. Nature 401 (1999) 93-98
40. Berndsen C.E., Albaugh B.N., Tan S., and Denu J.M. Catalytic mechanism of a MYST family histone acetyltransferase. Biochemistry 46 (2007) 623-629
41. Scheibner K.A., De Angelis J., Burley S.K., and Cole P.A. Investigation of the roles of catalytic residues in serotonin N-acetyltransferase. J Biol Chem 277 (2002) 18118-18126
42. Tanner K.G., Trievel R.C., Kuo M.H., Howard R.M., Berger S.L., Allis C.D., Marmorstein R., and Denu J.M. Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator. J Biol Chem 274 (1999) 18157-18160
43. Tang Y., Holbert M.A., Wurtele H., Meeth K., Rocha W., Gharib M., Jiang E., Thibault P., Verrault A., Cole P.A., et al. Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol 15 (2008) 738-745. This manuscript reported the structure of Rtt109 bound to acetyl-CoA as well as in vitro and in vivo studies of wild-type and mutant Rtt109 proteins to provide insights into catalysis and Vps75 binding by Rtt109.
44. Lau O.D., Kundu T.K., Soccio R.E., Ait-Si-Ali S., Khalil E.M., Vassilev A., Wolffe A.P., Nakatani Y., Roeder R.G., and Cole P.A. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5 (2000) 589-595
45. Collins S.R., Miller K.M., Maas N.L., Roguev A., Fillingham J., Chu C.S., Schuldiner M., Gebbia M., Recht J., Shales M., et al. Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature 446 (2007) 806-810
46. Santos-Rosa H., Valls E., Kouzarides T., and Martinez-Balbas M. Mechanisms of P/CAF auto-acetylation. Nucleic Acids Res 31 (2003) 4285-4292
47. Stavropoulos P., Nagy V., Blobel G., and Hoelz A. Molecular basis for the autoregulation of the protein acetyl transferase Rtt109. Proc Natl Acad Sci U S A 105 (2008) 12236-12241. See annotation to Ref. [43].
48. Lin C., and Yuan YA. Structural insights into histone H3 lysine 56 acetylation by Rtt109. Structure 16 (2008) 1503-1510. This manuscript reported the structure of Rtt109 alone and bound to acetyl-CoA as well as in vitro studies of wild-type and mutant Rtt109 proteins to provide insights into catalysis by Rtt109.
49. Holbert M.A., Sikorski T., Carten J., Snowflack D., Hodawadekar S., and Marmorstein R. The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting. J Biol Chem 282 (2007) 36603-36613
50. Troke P.J., Kindle K.B., Collins H.M., and Heery D.M. MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp (2006) 23-39
51. Qiao Y., Molina H., Pandey A., Zhang J., and Cole P.A. Chemical rescue of a mutant enzyme in living cells. Science 311 (2006) 1293-1297
52. Hwang Y., Thompson P.R., Wang L., Jiang L., Kelleher N.L., and Cole P.A. A selective chemical probe for coenzyme A-requiring enzymes. Angew Chem Int Ed Engl 46 (2007) 7621-7624